Breast Cancer EDGE Task Force outcomes clinical measures of pain

Shana Harrington, Laura Gilchrist, Antoinette Sander

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Pain is one of the most commonly reported impairments after breast cancer treatment affecting anywhere from 16% to 73% of breast cancer survivors. Despite the high reported incldence of pain from cancer and its treatments, the ability to evaluate cancer pain continues to be difficult due to the complexity of the disease and the subjective experience of pain. The Oncology Section Breast Cancer EDGE Task Force was created to evaluate the evidence behind clinical outcome measures in women diagnosed with breast cancer. Methods: The authors systematically reviewed the literature for pain outcome measures published in the research involving women diagnosed with breast cancer. The goal was to examine the reported psychometric properties that are reported in the literature in order to determine clinical utility. Results: Visual Analog Scale, Numeric Rating Scale, Pressure Pain Threshold, McGill Pain Questionnaire, McGill Pain Questionnaire - Short Form, Brief Pain Inventory and Brief Pain Inventory - Short Form were highly recommended by the Task Force. The Task Force was unable to recommend two measures for use in the breast cancer population at the present time. Conclusions: A variety of outcome measures were used to measure pain in women diagnosed with breast cancer. When assessing pain in women with breast cancer, researchers and clinicians need to determine whether a unidimensional or multidimensional tool is most appropriate as well as whether the tool has strong psychometric properties.

Original languageEnglish
Pages (from-to)13-21
Number of pages9
JournalRehabilitation Oncology
Volume32
Issue number1
StatePublished - 2014
Externally publishedYes

Fingerprint

Advisory Committees
Outcome Assessment (Health Care)
Breast Neoplasms
Pain
Pain Measurement
Psychometrics
Equipment and Supplies
Pain Threshold
Aptitude
Visual Analog Scale
Survivors
Research Personnel
Pressure
Therapeutics
Research
Population

All Science Journal Classification (ASJC) codes

  • Rehabilitation
  • Oncology
  • Oncology(nursing)
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Harrington, S., Gilchrist, L., & Sander, A. (2014). Breast Cancer EDGE Task Force outcomes clinical measures of pain. Rehabilitation Oncology, 32(1), 13-21.

Breast Cancer EDGE Task Force outcomes clinical measures of pain. / Harrington, Shana; Gilchrist, Laura; Sander, Antoinette.

In: Rehabilitation Oncology, Vol. 32, No. 1, 2014, p. 13-21.

Research output: Contribution to journalArticle

Harrington, S, Gilchrist, L & Sander, A 2014, 'Breast Cancer EDGE Task Force outcomes clinical measures of pain', Rehabilitation Oncology, vol. 32, no. 1, pp. 13-21.
Harrington S, Gilchrist L, Sander A. Breast Cancer EDGE Task Force outcomes clinical measures of pain. Rehabilitation Oncology. 2014;32(1):13-21.
Harrington, Shana ; Gilchrist, Laura ; Sander, Antoinette. / Breast Cancer EDGE Task Force outcomes clinical measures of pain. In: Rehabilitation Oncology. 2014 ; Vol. 32, No. 1. pp. 13-21.
@article{a4ff2e01f18948ddb768d1936a33868a,
title = "Breast Cancer EDGE Task Force outcomes clinical measures of pain",
abstract = "Background: Pain is one of the most commonly reported impairments after breast cancer treatment affecting anywhere from 16{\%} to 73{\%} of breast cancer survivors. Despite the high reported incldence of pain from cancer and its treatments, the ability to evaluate cancer pain continues to be difficult due to the complexity of the disease and the subjective experience of pain. The Oncology Section Breast Cancer EDGE Task Force was created to evaluate the evidence behind clinical outcome measures in women diagnosed with breast cancer. Methods: The authors systematically reviewed the literature for pain outcome measures published in the research involving women diagnosed with breast cancer. The goal was to examine the reported psychometric properties that are reported in the literature in order to determine clinical utility. Results: Visual Analog Scale, Numeric Rating Scale, Pressure Pain Threshold, McGill Pain Questionnaire, McGill Pain Questionnaire - Short Form, Brief Pain Inventory and Brief Pain Inventory - Short Form were highly recommended by the Task Force. The Task Force was unable to recommend two measures for use in the breast cancer population at the present time. Conclusions: A variety of outcome measures were used to measure pain in women diagnosed with breast cancer. When assessing pain in women with breast cancer, researchers and clinicians need to determine whether a unidimensional or multidimensional tool is most appropriate as well as whether the tool has strong psychometric properties.",
author = "Shana Harrington and Laura Gilchrist and Antoinette Sander",
year = "2014",
language = "English",
volume = "32",
pages = "13--21",
journal = "Rehabilitation Oncology",
issn = "2168-3808",
publisher = "American Physical Therapy Association",
number = "1",

}

TY - JOUR

T1 - Breast Cancer EDGE Task Force outcomes clinical measures of pain

AU - Harrington, Shana

AU - Gilchrist, Laura

AU - Sander, Antoinette

PY - 2014

Y1 - 2014

N2 - Background: Pain is one of the most commonly reported impairments after breast cancer treatment affecting anywhere from 16% to 73% of breast cancer survivors. Despite the high reported incldence of pain from cancer and its treatments, the ability to evaluate cancer pain continues to be difficult due to the complexity of the disease and the subjective experience of pain. The Oncology Section Breast Cancer EDGE Task Force was created to evaluate the evidence behind clinical outcome measures in women diagnosed with breast cancer. Methods: The authors systematically reviewed the literature for pain outcome measures published in the research involving women diagnosed with breast cancer. The goal was to examine the reported psychometric properties that are reported in the literature in order to determine clinical utility. Results: Visual Analog Scale, Numeric Rating Scale, Pressure Pain Threshold, McGill Pain Questionnaire, McGill Pain Questionnaire - Short Form, Brief Pain Inventory and Brief Pain Inventory - Short Form were highly recommended by the Task Force. The Task Force was unable to recommend two measures for use in the breast cancer population at the present time. Conclusions: A variety of outcome measures were used to measure pain in women diagnosed with breast cancer. When assessing pain in women with breast cancer, researchers and clinicians need to determine whether a unidimensional or multidimensional tool is most appropriate as well as whether the tool has strong psychometric properties.

AB - Background: Pain is one of the most commonly reported impairments after breast cancer treatment affecting anywhere from 16% to 73% of breast cancer survivors. Despite the high reported incldence of pain from cancer and its treatments, the ability to evaluate cancer pain continues to be difficult due to the complexity of the disease and the subjective experience of pain. The Oncology Section Breast Cancer EDGE Task Force was created to evaluate the evidence behind clinical outcome measures in women diagnosed with breast cancer. Methods: The authors systematically reviewed the literature for pain outcome measures published in the research involving women diagnosed with breast cancer. The goal was to examine the reported psychometric properties that are reported in the literature in order to determine clinical utility. Results: Visual Analog Scale, Numeric Rating Scale, Pressure Pain Threshold, McGill Pain Questionnaire, McGill Pain Questionnaire - Short Form, Brief Pain Inventory and Brief Pain Inventory - Short Form were highly recommended by the Task Force. The Task Force was unable to recommend two measures for use in the breast cancer population at the present time. Conclusions: A variety of outcome measures were used to measure pain in women diagnosed with breast cancer. When assessing pain in women with breast cancer, researchers and clinicians need to determine whether a unidimensional or multidimensional tool is most appropriate as well as whether the tool has strong psychometric properties.

UR - http://www.scopus.com/inward/record.url?scp=84894298118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894298118&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 13

EP - 21

JO - Rehabilitation Oncology

JF - Rehabilitation Oncology

SN - 2168-3808

IS - 1

ER -